Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 09:00 am Sale |
2024-12-31 | 13G | Axsome Therapeutics, Inc. AXSM |
RTW Investments, LP | 4,051,365 8.400% |
-438,231 (-9.76%) |
Filing History |
| 2024-02-14 3:46 pm Purchase |
2023-12-31 | 13G | Axsome Therapeutics, Inc. AXSM |
Fairmount Funds Management LLC | 2,360,077 4.900% |
15,097 (+0.64%) |
Filing History |
| 2024-02-14 07:26 am Purchase |
2023-12-31 | 13G | Axsome Therapeutics, Inc. AXSM |
RTW Investments, LP | 4,489,596 9.500% |
1,509,114 (+50.63%) |
Filing History |
| 2024-02-13 4:58 pm Purchase |
2023-12-29 | 13G | Axsome Therapeutics, Inc. AXSM |
The Vanguard Group | 3,696,766 7.810% |
279,138 (+8.17%) |
Filing History |
| 2024-01-26 5:25 pm Purchase |
2023-12-31 | 13G | Axsome Therapeutics, Inc. AXSM |
BlackRock Inc. BLK |
3,239,746 6.800% |
736,769 (+29.44%) |
Filing History |
| 2023-07-07 4:00 pm Purchase |
2023-06-28 | 13G | Axsome Therapeutics, Inc. AXSM |
Fairmount Funds Management LLC | 2,344,980 5.000% |
333,333 (+16.57%) |
Filing History |
| 2023-02-14 5:11 pm Sale |
2022-12-31 | 13G | Axsome Therapeutics, Inc. AXSM |
Venrock Healthcare Capital Partners II, L.P. | 0 0.000% |
-2,333,975 (Position Closed) |
Filing History |
| 2023-02-14 4:06 pm Sale |
2022-12-31 | 13G | Axsome Therapeutics, Inc. AXSM |
PFM Health Sciences, LP | 1,391,831 3.200% |
-767,902 (-35.56%) |
Filing History |
| 2023-02-14 3:45 pm Sale |
2022-12-31 | 13G | Axsome Therapeutics, Inc. AXSM |
Fairmount Funds Management LLC | 2,011,647 4.600% |
-155,000 (-7.15%) |
Filing History |
| 2023-02-14 10:07 am Purchase |
2022-12-31 | 13G | Axsome Therapeutics, Inc. AXSM |
RTW Investments, LP | 2,980,482 6.900% |
2,980,482 (New Position) |
Filing History |
| 2023-02-09 11:07 am Purchase |
2022-12-30 | 13G | Axsome Therapeutics, Inc. AXSM |
The Vanguard Group | 3,417,628 7.870% |
732,006 (+27.26%) |
Filing History |
| 2023-02-01 4:54 pm Purchase |
2022-12-31 | 13G | Axsome Therapeutics, Inc. AXSM |
BlackRock Inc. BLK |
2,502,977 5.800% |
393,355 (+18.65%) |
Filing History |
| 2022-10-25 9:09 pm Purchase |
2022-09-16 | 13G | Axsome Therapeutics, Inc. AXSM |
Fairmount Funds Management LLC | 2,166,647 5.400% |
2,166,647 (New Position) |
Filing History |
| 2022-10-24 4:01 pm Purchase |
2022-10-14 | 13G | Axsome Therapeutics, Inc. AXSM |
PFM Health Sciences, LP | 2,159,733 5.400% |
2,159,733 (New Position) |
Filing History |
| 2022-02-09 3:24 pm Purchase |
2021-12-31 | 13G | Axsome Therapeutics, Inc. AXSM |
The Vanguard Group | 2,685,622 7.130% |
44,548 (+1.69%) |
Filing History |
| 2022-02-03 4:41 pm Sale |
2021-12-31 | 13G | Axsome Therapeutics, Inc. AXSM |
BlackRock Inc. BLK |
2,109,622 5.600% |
-170,144 (-7.46%) |
Filing History |
| 2022-01-18 3:45 pm Sale |
2021-12-31 | 13G | Axsome Therapeutics, Inc. AXSM |
IRIDIAN ASSET MANAGEMENT LLC | 0 0.000% |
-2,064,158 (Position Closed) |
Filing History |
| 2021-02-10 10:39 am Purchase |
2020-12-31 | 13G | Axsome Therapeutics, Inc. AXSM |
The Vanguard Group | 2,641,074 7.070% |
2,641,074 (New Position) |
Filing History |
| 2021-02-04 08:32 am Purchase |
2020-12-31 | 13G | Axsome Therapeutics, Inc. AXSM |
IRIDIAN ASSET MANAGEMENT LLC | 2,064,158 5.500% |
2,064,158 (New Position) |
Filing History |
| 2021-01-28 5:55 pm Purchase |
2020-12-31 | 13G | Axsome Therapeutics, Inc. AXSM |
BlackRock Inc. BLK |
2,279,766 6.100% |
119,520 (+5.53%) |
Filing History |